Evolent Health EBITDA vs. Price To Book
| EVH Stock | USD 12.92 0.01 0.08% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -24.8 M | Current Value -26 M | Quarterly Volatility 132.2 M |
For Evolent Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evolent Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evolent Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evolent Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evolent Health over time as well as its relative position and ranking within its peers.
Evolent |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 21.554 | Quarterly Revenue Growth 0.216 | Return On Assets 0.0073 | Return On Equity (0.06) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evolent Health Price To Book vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Evolent Health's current stock value. Our valuation model uses many indicators to compare Evolent Health value to that of its competitors to determine the firm's financial worth. Evolent Health is rated below average in ebitda category among its peers. It also is rated below average in price to book category among its peers . As of now, Evolent Health's EBITDA is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolent Health's earnings, one of the primary drivers of an investment's value.Evolent Price To Book vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Evolent Health |
| = | (24.79 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Evolent Health |
| = | 1.43 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Evolent Price To Book Comparison
Evolent Health is currently under evaluation in price to book category among its peers.
Evolent Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Evolent Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Evolent Health will eventually generate negative long term returns. The profitability progress is the general direction of Evolent Health's change in net profit over the period of time. It can combine multiple indicators of Evolent Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.3 M | -1.3 M | |
| Operating Income | -71.2 M | -74.8 M | |
| Income Before Tax | -202.4 M | -192.3 M | |
| Total Other Income Expense Net | -131.2 M | -124.6 M | |
| Net Loss | -113 M | -118.7 M | |
| Income Tax Expense | -89.4 M | -84.9 M | |
| Net Loss | -113 M | -118.7 M | |
| Net Loss | -17.2 M | -18.1 M | |
| Interest Income | 5.3 M | 4.9 M | |
| Non Operating Income Net Other | 5.4 M | 5.1 M | |
| Net Interest Income | -48.9 M | -46.5 M | |
| Change To Netincome | -31 M | -29.4 M | |
| Net Loss | (1.02) | (1.07) | |
| Income Quality | (1.26) | (1.20) | |
| Net Income Per E B T | 0.56 | 0.92 |
Evolent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Evolent Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Evolent Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Evolent Health's important profitability drivers and their relationship over time.
Use Evolent Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.Evolent Health Pair Trading
Evolent Health Pair Trading Analysis
The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.
The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Evolent Health position
In addition to having Evolent Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks - Regional Thematic Idea Now
Banks - Regional
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banks - Regional theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks - Regional Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project Evolent Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Evolent Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Evolent Health's income statement, its balance sheet, and the statement of cash flows.